ArticleViruses2022

In Silico Screening and Testing of FDA-Approved Small Molecules to Block SARS-CoV-2 Entry to the Host Cell by Inhibiting Spike Protein Cleavage.

E Sila Ozdemir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.